Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Kim D, Day DF. A new process for the production of clinical dextran by mixed-culture fermentation of Lipomyces starkeyi and Leuconostoc mesenteroides. Enzyme Microb. Technol. 16: 844-848, 1994. PubMed: 7521648
Day DF, Kim D. Process for the production of dextran polymers of controlled molecular size and molecular size distributions. US Patent 5,229,277 dated Jul 20 1993
Kim D, Day DF. Isolation of a dextranase constitutive mutant of Lipomyces starkeyi and its use for the production of clinical size dextran. Lett. Appl. Microbiol. 20: 268-270, 1995. PubMed: 7766225
